Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Daniel O’Mahony

Daniel O’Mahony

Partner, Seroba Life Sciences

A Partner at Seroba Life Sciences and brings a wealth of experience from pharma industry in product development, strategic planning, licensing, corporate venturing and technology commercialisation. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management and has held academic appointments in Ireland and USA. He currently sits on a number of boards include Atlantic Therapeutics, ATXA Therapeutics and PQ Bypass.  He previously sat on the boards of Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Janssen), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation).

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd